Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021

BUY
$3.44 - $4.24 $68,800 - $84,800
20,000 New
20,000 $21,000
Q1 2021

May 12, 2021

SELL
$4.19 - $5.99 $67,040 - $95,840
-16,000 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
$3.27 - $4.87 $3,270 - $4,870
-1,000 Reduced 5.88%
16,000 $64,000
Q3 2020

Nov 09, 2020

SELL
$2.99 - $5.96 $1,495 - $2,980
-500 Reduced 2.86%
17,000 $63,000
Q2 2020

Aug 13, 2020

BUY
$1.15 - $3.41 $1,724 - $5,115
1,500 Added 9.38%
17,500 $59,000
Q1 2020

May 12, 2020

SELL
$1.34 - $2.32 $9,380 - $16,239
-7,000 Reduced 30.43%
16,000 $20,000
Q4 2019

Jan 28, 2020

SELL
$1.42 - $2.17 $3,550 - $5,425
-2,500 Reduced 9.8%
23,000 $31,000
Q3 2019

Oct 22, 2019

SELL
$1.75 - $2.47 $4,165 - $5,878
-2,380 Reduced 8.54%
25,500 $51,000
Q2 2019

Jul 18, 2019

BUY
$1.79 - $2.61 $6,945 - $10,126
3,880 Added 16.17%
27,880 $65,000
Q1 2019

May 06, 2019

SELL
$2.42 - $3.83 $58,080 - $91,920
-24,000 Reduced 50.0%
24,000 $64,000
Q1 2019

May 01, 2019

BUY
$2.42 - $3.83 $73,810 - $116,815
30,500 Added 174.29%
48,000 $128,000
Q4 2018

Feb 13, 2019

SELL
$2.46 - $3.87 $7,380 - $11,610
-3,000 Reduced 14.63%
17,500 $54,000
Q3 2018

Nov 14, 2018

SELL
$3.29 - $6.29 $18,917 - $36,167
-5,750 Reduced 21.9%
20,500 $69,000
Q2 2018

Aug 14, 2018

BUY
$2.99 - $4.99 $2,990 - $4,990
1,000 Added 3.96%
26,250 $126,000
Q1 2018

May 18, 2018

SELL
$3.11 - $5.12 $777 - $1,280
-250 Reduced 0.98%
25,250 $80,000
Q4 2017

Feb 13, 2018

SELL
$4.61 - $7.04 $11,064 - $16,896
-2,400 Reduced 8.6%
25,500 $126,000
Q3 2017

Nov 16, 2017

BUY
$5.88 - $7.11 $34,868 - $42,162
5,930 Added 26.99%
27,900 $192,000
Q2 2017

Aug 15, 2017

BUY
N/A
21,970
21,970 $147,000

Others Institutions Holding OPK

About OPKO HEALTH, INC.


  • Ticker OPK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 771,960,000
  • Market Cap $1.12B
  • Description
  • OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...
More about OPK
Track This Portfolio

Track Moors & Cabot, Inc. Portfolio

Follow Moors & Cabot, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.